QMM principles and practices can positively influence a sustainable drug supply and bolster the bottom-line of drug manufacturers, API suppliers, and CMO/CDMOs.
Zachary Royal
Advertisement
Zachary Royal, is senior consultant at Shabas Solutions LLC.
Articles by Zachary Royal
QMM is an evolutionary advancement in FDA’s quality management maturity initiative that provides industry with a viable methodology to assess and improve manufacturing quality and supply chain reliability.
Advertisement
Latest Updated Articles
QMM for Pharmaceutical Manufacturers– Implications for Drug Manufacturers, API Suppliers and Contract ManufacturersPublished: May 2nd 2023 | Updated:
Introduction to Pharmaceutical QMM Model: QMM Assessment to Promote Pharmaceutical Operational ExcellencePublished: December 3rd 2022 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
The Key Trends Driving Supply Chain Localization and Data Scrutiny in Biopharma
2
Excipient Innovation, Safer Solvents, and Supply Chain Resilience
3
Turning Real-World Data into Actionable Drug Development Insights With AI
4
The Bio/pharma Industry Navigates AI’s Impact on Workforce and Hiring
5
